Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S ADR
(NY:
NVO
)
136.97
+0.09 (+0.07%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,112,197
Open
136.57
Bid (Size)
135.28 (1)
Ask (Size)
136.97 (3)
Prev. Close
136.88
Today's Range
135.92 - 137.15
52wk Range
86.96 - 148.15
Shares Outstanding
N/A
Dividend Yield
1.29%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets
August 23, 2024
Analysts expect Novo Nordisk's Ozempic and other major drugs to be included in 2027 Medicare price negotiations. Despite concerns, experts predict limited financial impact on companies like Pfizer,...
Via
Benzinga
RedHill's Opaganib Shows Diabetes And Obesity Potential With Positive In Vivo Results
August 23, 2024
RedHill's Opaganib Shows Diabetes And Obesity Potential With Positive In Vivo Results
Via
News Direct
Performance
YTD
+34.14%
+34.14%
1 Month
+4.08%
+4.08%
3 Month
+0.68%
+0.68%
6 Month
+10.95%
+10.95%
1 Year
+47.80%
+47.80%
More News
Read More
These Were the Top-Selling GLP-1 Drugs Last Quarter From Eli Lilly and Novo Nordisk
August 23, 2024
Via
The Motley Fool
Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead
August 23, 2024
Via
The Motley Fool
What the Options Market Tells Us About Novo Nordisk
August 22, 2024
Via
Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $5,900 Today
August 20, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Novo Nordisk Through 8 Analysts
August 19, 2024
Via
Benzinga
Unpacking the Latest Options Trading Trends in Novo Nordisk
August 15, 2024
Via
Benzinga
Wegovy Now Available Through Sesame's $249 Monthly Compounded Program Despite Supply Shortages
August 21, 2024
Via
Benzinga
Novo Nordisk Vs. Eli Lilly: Beyond The Weight-Loss Drug Battle
August 21, 2024
Via
Benzinga
Topics
Economy
Exposures
Supply Chain
Eli Lilly Stock Could Soar to $1,150, According to a Wall Street Analyst. Is It a Buy at Around $945?
August 21, 2024
Via
The Motley Fool
Ozempic And Wegovy Linked to Increased Suicidal Thoughts In Observational Study, But Results Are Contested
August 20, 2024
Via
Benzinga
Soviet Code Breaker Jim Simons' Hedge Fund Renaissance Technologies — Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings
August 19, 2024
Via
Benzinga
Telehealth Firm Hims & Hers Health Rides High On Demand for Copycat Weight Loss Drugs Amid Supply Shortages
August 19, 2024
Via
Benzinga
Prediction: These 2 Unstoppable Pharma Stocks Will Continue to Soar Through 2025 and Beyond
August 19, 2024
Via
The Motley Fool
Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived
August 18, 2024
Via
The Motley Fool
Novo Nordisk and Eli Lilly Could Have a Big Rival in the GLP-1 Market in a Few Years
August 18, 2024
Via
The Motley Fool
These 3 Healthcare Companies Had the Top-Selling Drugs Last Year
August 18, 2024
Via
The Motley Fool
Is Madrigal Pharmaceuticals Stock a Buy?
August 17, 2024
Via
The Motley Fool
3 Fantastic Growth Stocks to Buy in August
August 17, 2024
Via
The Motley Fool
Could Viking Therapeutics Become the Next Novo Nordisk?
August 17, 2024
Via
The Motley Fool
Doctors Struggle to Secure Medicare Coverage for Heart Patients on Novo Nordisk's Wegovy
August 16, 2024
Via
Benzinga
Roche Misses Out On Weight-Loss Blockbuster Drug, Now Playing Catch-Up In Booming Market
August 16, 2024
Via
Benzinga
Prediction: Up 74% So Far This Year, This Weight Loss Stock Is About to Crater
August 16, 2024
Via
The Motley Fool
Prediction: This Company Will Disrupt Eli Lilly and Novo Nordisk in the Weight Loss Market (Hint: It's Not Pfizer)
August 15, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.